Netherlands

5 Vaccines Approved for Use in Netherlands

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Approval Source: ema.europa.eu
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: ema.europa.eu
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu

7 in Clinical Trials in Netherlands

Protein Subunit

University Medical Center Groningen

AKS-452

4 trials in 2 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Protein Subunit

University Medical Center Groningen

AKS-452X

VLP

Radboud University

ABNCoV2

4 trials in 2 countries
Inactivated

Valneva

VLA2001

Approved in 3 countries
6 trials in 3 countries

1 Vaccines with Trials in Netherlands are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries